MARKET

ALPN

ALPN

Alpine Immune
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.370
-0.430
-11.32%
Closed 16:00 01/17 EST
OPEN
3.833
PREV CLOSE
3.800
HIGH
3.855
LOW
3.370
VOLUME
22.70K
TURNOVER
--
52 WEEK HIGH
8.24
52 WEEK LOW
2.250
MARKET CAP
62.64M
P/E (TTM)
-1.2210
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ALPN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ALPN News

  • Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares This Year?
  • Simply Wall St..5d ago
  • Alpine Immune Sciences Announces Poster Presentation at 2020 Crohn’s & Colitis Congress
  • Business Wire.01/06 12:30
  • Is Alpine Immune Sciences, Inc. (ALPN) A Good Stock To Buy?
  • Insider Monkey.12/22/2019 18:52
  • Alpine Immune Sciences Presents ALPN-101 Phase 1 Healthy Volunteer Study Data and Details of Upcoming Phase I/II BALANCE GVHD Study at the 61st American Society of Hematology Annual Meeting
  • Business Wire.12/09/2019 12:30

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About ALPN

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a process known as directed evolution. The vlgD platform exploits both known and unknown interactions at immune synapse through a process called direct evolution for patients living with cancer, autominnue/inflammatory conditions and chronic infectious disease. It optimizes native immune system proteins for use as therapeutics. The Company also developed Transmembrane Immunomodulatory Protien (TIP) technology, based on the vIgD platform, to enhance engineered cellular therapies. TIP program is created to help companies focused on engineered cellular therapies.
More

Webull offers Alpine Immune Sciences Inc (ALPN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.